Effects of lesions of the central nucleus of the amygdala on anxiety-like behaviors in the rat

doi:10.1016/0091-3057(92)90176-G

Pharmacology Biochemistry and Behavior

Volume 43, Issue 2, October 1992, Pages 453-461

https://doi.org/10.1016/0091-3057(92)90176-G Get rights and content

Abstract

The effects of lesions of the central nucleus of the amygdala on anxiety-like behaviors in the rat were determined using two animal models, the conditioned suppression of drinking (CSD) and defensive burying paradigms. For CSD conflict testing, water-restricted rats were trained to drink water from a tube that was occasionally electrified (0.25 mA); electrification was signaled by a tone. CSD test sessions were 10 min in duration and were conducted 4 days per week. After at least 3 weeks of conflict testing, both punished (30–40 shocks per session) and unpunished (10–12 ml water per session) responding had stabilized. Subjects then received bilateral electrolytic lesions of the central nucleus of the amygdala or sham lesions. After a 1-week recovery period, CSD conflict testing was reinstated and continued for 20 weeks. Amygdaloid-lesioned subjects accepted significantly more shocks than did sham controls. In addition, acute challenges with the benzodiazepine chlordiazepoxide (2.5–10 mg/kg, IP, 30-min pretreatment), the barbiturate phenobarbital (20 mg/kg, IP, 10-min pretreatment), and carbamazepine (10 mg/kg, IP, 10-min pretreatment) produced an increase in punished responding in both amygdaloid-lesioned and sham-treated subjects. Analysis of covariance (ANCOVA)-based adjusted means for the change in shocks received were not significantly different between the two groups. Following completion of the CSD studies, subjects were tested in the defensive burying paradigm. Although there was no significant difference between lesioned and sham-treated subjects on the percent of animals that exhibited burying, subjects with lesions of the central nucleus of the amygdala exhibited a significantly greater latency to initiate defensive burying. Lesioned subjects also exhibited a shorter duration of defensive burying than sham-treated subjects; however, this difference was not statistically significant. These data suggest that although the central nucleus of the amygdala contributes to baseline anxiety-like behaviors the anxiolytic-like effects of chlordiazepoxide, phenobarbital, and carbamazepine do not appear to be dependent upon the integrity of this amygdaloid nucleus.

References (40)

C.D. Applegate et al.
Autonomic and somatomotor effects of amygdala central nucleus stimulation in awake rabbits
Physiol. Behav.
(1983)
S.L. Beardslee et al.
Antipanic drug treatments: Failure to exhibit anxiolytic-like effects on defensive burying behavior
Pharmacol. Biochem. Behav.
(1990)
R.L. Commissaris et al.
Maudsley reactive and non-reactive rats strains: Differential response in a conflict task
Physiol. Behav.
(1986)
R.M. Craft et al.
Conditioned defensive burying as a model for identifying anxiolytics
Pharmacol. Biochem. Behav.
(1988)
J.M. Hitchcock et al.
Fear-potentiated startle using an auditory conditioned stimulus: Effect of lesions of the amygdala
Physiol. Behav.
(1987)
T.C. McCloskey et al.
Buspirone effects in an animal conflict behavior: Comparison with diazepam and phenobarbital
Pharmacol. Biochem. Behav.
(1987)
J. Nagy et al.
Anti-anxiety action of diazepam after intraamygdaloid application in the rat
Neuropharmacology
(1979)
E.N. Petersen et al.
Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors
Neurosci. Lett.
(1985)
J.B. Rosen et al.
Temporal characteristics of enhancement of startle by stimulation of the amygdala
Physiol. Behav.
(1988)
J. Scheel-Kruger et al.
Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala
Eur. J. Pharmacol.
(1982)

K. Shibata et al.

Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats

Brain Res.

(1982)

K. Shibata et al.

An important role of the central amygdaloid nucleus and mammillary body in the mediation of conflict behavior in rats

Brain Res.

(1986)

S.R. Thomas et al.

Correlation of [³H]diazepam binding density with anxiolytic locus in the amygdaloid complex of the rat

Brain Res.

(1985)

D. Treit et al.

A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics

Pharmacol. Biochem. Behav.

(1988)

D. Treit et al.

Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action

Physiol. Behav.

(1990)

D. Treit et al.

Conditioned defensive burying: A new paradigm for the study of anxiolytic agents

Pharmacol. Biochem. Behav.

(1981)

H. Ursin et al.

Functional localization within the amygdaloid complex in the cat

Electroencephalogr. Clin. Neurophysiol.

(1960)

K. Yamashita et al.

Neuroanatomical substrates regulating rat conflict behavior evidenced by brain lesioning

Neurosci. Lett.

(1989)

R.N. Almeida et al.

Effects of acute or chronic carbamazepine on experimentally-induced conflict in the rat

Psychopharmacology (Berl.)

(1990)

R.J. Baldessarini

Drugs and the treatment of psychiatric disorders

Cited by (66)

Substance P: A neuropeptide involved in the psychopathology of anxiety disorders
2020, Neuropeptides
Substance P (SP) is the most widely distributed neuropeptide in central nervous system (CNS) where it participates in numerous physiological and pathophysiological processes including stress and anxiety related behaviors. In line with this notion, brain areas that are thought to be involved in anxiety regulation contains SP and its specific NK1 receptors. SP concentration in different brain regions alters with the exposure of stressful stimulus and affected NK1 receptor binding is observed. SP is released in response to a stressor, which produces anxiogenic effects via activation of hypothalamic-pituitary-adrenal (HPA) axis, resulting in the liberation of cortisol. Moreover, SP is also involved in the activation of the sympathetic nervous system via stimulation of locus coeruleus (LC). This sympathetic surge initiates cortisol discharge by activation of HPA axis, representing the indirect anxiogenic effect of SP. Besides the aforementioned regions, SP also has an impact on other brain regions known to be involved in stress and anxiety mechanisms, including amygdala, lateral septum (LS), periaqueductal gray (PAG), ventromedial nucleus of the hypothalamus (VMH), and bed nucleus of stria terminalis (BNST). Thus, SP acts as an important neuromodulator in various brain regions in stress and anxiety response. Consistent with the above statement, SP makes a robust link in the psychopathology of anxiety disorders. As SP concentration is found elevated in stressed conditions, several studies have reported that the pharmacological antagonism or genetic depletion of NK-1 receptors results in the anxiolytic response making them a suitable therapeutic target for the treatment of stress and anxiety related disorders.
Estrogen receptors α and β in the central amygdala and the ventromedial nucleus of the hypothalamus: Sociosexual behaviors, fear and arousal in female rats during emotionally challenging events
2019, Behavioural Brain Research
Estrogens receptors (ER) are involved in several sociosexual behaviors and fear responses. In particular, the ERα is important for sexual behaviors, whereas ERβ modulates anxiolytic responses. Using shRNA directed either against the ERα or the ERβ RNAs (or containing luciferase control) encoded within an adeno-associated viral vector, we silenced these receptors in the ventromedial nucleus of the hypothalamus (VMN) and the central amygdala (CeA). We exposed ovariectomized female rats, sequentially treated with estradiol benzoate and progesterone, to five stimuli, previously reported to elicit positive and negative affect. The subjects were housed in groups of 4 females and 3 males in a seminatural environment for several days before hormone treatment. We analyzed the frequency of a large number of behavior patterns. In addition, we performed analyses of co-occurrence in order to detect changes in the structure of behavior after infusion of the vectors. Silencing the ERα in the VMN disrupted lordosis and showed some anxiolytic properties in aversive situations, whereas silencing of the ERβ in this structure had no effect. This was also the case after silencing the ERα in the CeA. Silencing of the ERβ in this structure increased risk assessment, an expression of anxiety, and increased olfactory exploration of the environment. We hypothesize that the ERβ in the CeA has an important role in the well-established anxiolytic effects of estrogens, and that it may modulate arousal level. Furthermore, it seems that the ERα in the VMN is anxiogenic in aversive or threatening situations, in agreement with other studies.
Cocaine- and amphetamine-regulated transcript (CART): A multifaceted neuropeptide
2018, Peptides
Citation Excerpt :
Moreover, since intra-CeA administration of CART induced antidepressant phenotype in the rats, CART could be considered as a novel therapeutic target for treatment of depression [215]. Localization of the CART peptides in the amygdala and LC suggests that CART peptides might be the important transmitter signal that mediates the behavioral response to stress [34,216,217]. Supporting evidence showed that the exposure of rats to chronic cold, restraint, and forced swimming stress also increased the level of the CART peptides in the hippocampus, arcuate, and periventricular neurons [56–58].
Over the last 35 years, the continuous discovery of novel neuropeptides has been the key to the better understanding of how the central nervous system has integrated with neuronal signals and behavioral responses. Cocaine and amphetamine-regulated transcript (CART) was discovered in 1995 in the rat striatum but later was found to be highly expressed in the hypothalamus. The widespread distribution of CART peptide in the brain complicated the understanding of the role played by this neurotransmitter. The main objective of the current compact review is to piece together the fragments of available information about origin, expression, distribution, projection, and function of CART peptides. Accumulative evidence suggests CART as a neurotransmitter and neuroprotective agent that is mainly involved in regulation of feeding, addiction, stress, anxiety, innate fear, neurological disease, neuropathic pain, depression, osteoporosis, insulin secretion, learning, memory, reproduction, vision, sleep, thirst and body temperature. In spite of the vast number of studies about the CART, the overall pictures about the CART functions are sketchy. First, there is a lack of information about cloned receptor, specific agonist and antagonist. Second, CART peptides are detected in discrete sets of neurons that can modulate countless activities and third; CART peptides exist in several fragments due to post-translational processing. For these reasons the overall picture about the CART peptides are sketchy and confounding.
Animal to human translational paradigms relevant for approach avoidance conflict decision making
2017, Behaviour Research and Therapy
Avoidance behavior in clinical anxiety disorders is often a decision made in response to approach-avoidance conflict, resulting in a sacrifice of potential rewards to avoid potential negative affective consequences. Animal research has a long history of relying on paradigms related to approach-avoidance conflict to model anxiety-relevant behavior. This approach includes punishment-based conflict, exploratory, and social interaction tasks. There has been a recent surge of interest in the translation of paradigms from animal to human, in efforts to increase generalization of findings and support the development of more effective mental health treatments. This article briefly reviews animal tests related to approach-avoidance conflict and results from lesion and pharmacologic studies utilizing these tests. We then provide a description of translational human paradigms that have been developed to tap into related constructs, summarizing behavioral and neuroimaging findings. Similarities and differences in findings from analogous animal and human paradigms are discussed. Lastly, we highlight opportunities for future research and paradigm development that will support the clinical utility of this translational work.
The role of the hippocampus in approach-avoidance conflict decision-making: Evidence from rodent and human studies
2016, Behavioural Brain Research
The hippocampus (HPC) has been traditionally considered to subserve mnemonic processing and spatial cognition. Over the past decade, however, there has been increasing interest in its contributions to processes beyond these two domains. One question is whether the HPC plays an important role in decision-making under conditions of high approach-avoidance conflict, a scenario that arises when a goal stimulus is simultaneously associated with reward and punishment. This idea has its origins in rodent work conducted in the 1950s and 1960s, and has recently experienced a resurgence of interest in the literature. In this review, we will first provide an overview of classic rodent lesion data that first suggested a role for the HPC in approach-avoidance conflict processing and then proceed to describe a wide range of more recent evidence from studies conducted in rodents and humans. We will demonstrate that there is substantial, converging cross-species evidence to support the idea that the HPC, in particular the ventral (in rodents)/anterior (in humans) portion, contributes to approach-avoidance conflict decision making. Furthermore, we suggest that the seemingly disparate functions of the HPC (e.g. memory, spatial cognition, conflict processing) need not be mutually exclusive.
Nuance and behavioral cogency: How the Visible Burrow System inspired the Stress-Alternatives Model and conceptualization of the continuum of anxiety
2015, Physiology and Behavior
By creating the Visible Burrow System (VBS) Bob Blanchard found a way to study the interaction of genetics, physiology, environment, and adaptive significance in a model with broad validity. The VBS changed the way we think about anxiety and affective disorders by allowing the mechanisms which control them to be observed in a dynamic setting. Critically, Blanchard used the VBS and other models to show how behavioral systems like defense are dependent upon context and behavioral elements unique to the individual. Inspired by the VBS, we developed a Stress Alternatives Model (SAM) to further explore the multifaceted dynamics of the stress response with a dichotomous choice condition. Like the VBS, the SAM is a naturalistic model built upon risk-assessment and defensive behavior, but with a choice of response: escape or submission to a large conspecific aggressor. The anxiety of novelty during the first escape must be weighed against fear of the aggressor, and a decision must be made. Both outcomes are adaptively significant, evidenced by a 50/50 split in outcome across several study systems. By manipulating the variables of the SAM, we show that a gradient of anxiety exists that spans the contextual settings of escaping an open field, escaping from aggression, and submitting to aggression. These findings correspond with increasing levels of corticosterone and increasing levels of NPS and BDNF in the central amygdala as the context changes. Whereas some anxiolytics were able to reduce the latency to escape for some animals, only with the potent anxiolytic drug antalarmin (CRF₁R-blocker) and the anxiogenic drug yohimbine (α₂ antagonist) were we able to reverse the outcome for a substantial proportion of individuals. Our findings promote a novel method for modeling anxiety, offering a distinction between low-and-high levels, and accounting for individual variability. The translational value of the VBS is immeasurable, and it guided us and many other researchers to seek potential clinical solutions through a deeper understanding of regional neurochemistry and gene expression in concert with an ecological behavioral model.

View all citing articles on Scopus

View full text

Effects of lesions of the central nucleus of the amygdala on anxiety-like behaviors in the rat

Abstract

Physiol. Behav.

Pharmacol. Biochem. Behav.

Physiol. Behav.

Pharmacol. Biochem. Behav.

Physiol. Behav.

Pharmacol. Biochem. Behav.

Neuropharmacology

Neurosci. Lett.

Physiol. Behav.

Eur. J. Pharmacol.

Brain Res.

Brain Res.

Brain Res.

Pharmacol. Biochem. Behav.

Physiol. Behav.

Pharmacol. Biochem. Behav.

Electroencephalogr. Clin. Neurophysiol.

Neurosci. Lett.

Effects of acute or chronic carbamazepine on experimentally-induced conflict in the rat

Psychopharmacology (Berl.)

Drugs and the treatment of psychiatric disorders